Apellis Pharmaceuticals (APLS) Competitor Comparison
We are evaluating the key criteria listed to compare Apellis Pharmaceuticals (APLS) against its competitors in the Biotechnology industry.
Market Capitalization
23 / 368Gross Profits
55 / 278Total Revenue
44 / 300EBITDA
328 / 337Free Cashflow
346 / 352Quick Ratio
243 / 357Earnings per Share
213 / 359Dividend yield
0 / 6Total Cash
68 / 358Performance 3 years
130 / 368Performance 5 years
128 / 368Performance 10 years
62 / 368Linearity 3 years
37 / 368Linearity 5 years
3 / 368Linearity 10 years
69 / 368Total Rank
122 / 368Dividend Rank
351 / 368Valuation Rank
180 / 368Piotroski Rank
76 / 368Muliplier Rank
270 / 368Valuation Rank - APLS ranking 180 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.